You searched for T cells - Page 27 of 41

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…part of a drug regimen to treat chronic granulomatous disease (CGD); Buphenyl, used to treat urea cycle disorders; Krystexxa, to treat gout; Procysbi, to treat nephropathic cystinosis; Ravicti, to manage…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

News and Trends 2 Jun 2023

Faux filet: World’s first 3D-printed ready-to-cook fish produced

…that are grown in laboratories, are obtained from the startup’s proprietary 3D bioprinters and customized bio-inks. Said to have the same taste and texture as traditionally caught fish, this invention…

June 2, 2023 - 3 minutesmins - By Roohi Mariam Peter

News and Trends 30 Jan 2018

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

…a Phase I trial to select a dose that can be used at Phase II to test the combination’s safety and efficacy. Durvalumab is a checkpoint inhibitor that blocks PD-L1…

January 30, 2018 - 3 minutesmins - By Alex Dale

CRISPR, CRISPR-Cas9, genome-editing, gene therapy

News and Trends 8 Sep 2022

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

…all rodent cells derived from these genetically modified rodent animals. It also includes the genetic manipulation of rodent embryonic stem cells and rodent embryos to create genetically modified rodent animals….

September 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 28 Sep 2018

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

…cells called regulatory T cells. These cells hold back the immune system from attacking tumors, thus the antibody helps the patient’s immune system to fight the cancer. The antibody has…

September 28, 2018 - 2 minutesmins - By Jonathan Smith

Best in Biotech 5 Mar 2025

Seven biotech companies keeping Taiwan dynamic in 2025

…cytotoxic agent specifically to TROP2-expressing cancer cells, to minimize damage to normal tissues. Preclinical studies have demonstrated promising anti-tumor activity, leading to the advancement of OBI-992 into clinical development. In…

March 5, 2025 - 8 minutesmins - By Jules Adam

Startup Scout 6 Sep 2023

Meet the startup developing novel cancer therapies from snake venom crotoxin

…that has an inbuilt targeting mechanism and selectivity for tumor cells. The therapy contains two subunits: A and B. “Once injected into the body via infusion pump, the A subunit…

September 6, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 27 Nov 2017

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

…phagocytic cells to remove pathogens, could be a candidate to quickly take care of the infection. Complement coats the virus, making it easier for the immune system to detect and…

November 27, 2017 - 3 minutesmins - By Alex Dale

News and Trends 27 Mar 2018

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

…whether a tumor is benign or malignant. “There are several major advantages to the circulating tumor cell technology. The first is it’s epitope or label-independent, so it doesn’t require the…

March 27, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 31 May 2017

German Biotech Enters the Clinic with Next-Generation Antibody for AML

…immuno-oncology candidate targeting the TRAIL-receptor. Apart from that, CAR-T pioneers such as Cellectis and Celyad or Juno are racing to treat leukemia including AML or ALL using their engineered killer…

May 31, 2017 - 2 minutesmins - By Melanie De Almeida

blood cancer stem cell therapy brain cancer

News and Trends 11 Sep 2019

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

…cells. In the lab, Genenta makes the stem cells mature into immune cells called tumor-infiltrating monocytes, and the company implants them into the patient’s tumor where they can recruit the…

September 11, 2019 - 3 minutesmins - By Jonathan Smith

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…cells to treat cancer. The two companies will assess the combination therapies’ performances in preclinical studies next year. The FLEX-NK antibodies are based on a tetravalent, multifunctional format with flexible…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

10 biotech companies making a difference in rare diseases

Faux filet: World’s first 3D-printed ready-to-cook fish produced

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

Seven biotech companies keeping Taiwan dynamic in 2025

Meet the startup developing novel cancer therapies from snake venom crotoxin

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis

German Biotech Enters the Clinic with Next-Generation Antibody for AML

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!